Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Udayana
Kadek Ida Krisnadewi
Universitas Bali Internasional
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
A Comparative Study of Health Utility Value and in Type 2 Diabetes Mellitus Patients Treated With Oral Monotherapy or In Combination with Oral or Insulin Kadek Ida Krisnadewi; Kadek Hendra Darmawan; Dewayu Satrya Dewi
Jurnal Farmasi Udayana Vol 15, No 1, Tahun 2026
Publisher : Departement of Pharmacy, Faculty of Mathematics and Natural Science, Udayana University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24843/JFU.2026.v15.i01.p01

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic disease with a high clinical and economic burden. This study aimed to compare health utility values and costs among T2DM patients receiving different therapeutic regimens, including oral monotherapy, oral combination therapy, insulin monotherapy, insulin combination therapy, and oral–insulin combination therapy. This study used an analytical observational design with a cross-sectional approach involving 119 patients. Data were collected using a structured questionnaire for patient characteristics and the EQ-5D-5L instrument to assess utility values, while cost analysis was conducted from the patient perspective, including direct and indirect costs. The results showed that oral monotherapy had the highest utility value (QALY 23.89) and a cost of Rp406.941,25 per patient/month, making it the most cost-effective therapy. In contrast, insulin-based therapies tended to have higher costs and lower utility values. Cost variations were observed across all components, with the highest drug costs found in insulin monotherapy. In conclusion, oral therapy, particularly monotherapy, represents the most economically and clinically efficient option. Early intervention and optimal disease management are essential to prevent disease progression and reduce long-term economic burden.
Co-Authors Dewayu Satrya Dewi Kadek Hendra Darmawan